Once-daily tiotropium Respimat® add-on to at least medium- to high-dose ICS, with or without LABA, improves lung function in patients with symptomatic asthma, independent of allergic status

Eric D Bateman; Thomas B Casale; E Pizzichini; Mark Vandewalker; JC Virchow; M Engel

Once-daily tiotropium Respimat® add-on to at least medium- to high-dose ICS, with or without LABA, improves lung function in patients with symptomatic asthma, independent of allergic status

Eric D Bateman, Thomas B Casale, E Pizzichini, Mark Vandewalker, JC Virchow, M Engel

Publikation: Konferencebidrag uden forlag/tidsskrift › Poster › Forskning › peer review

Originalsprog	Engelsk
Publikationsdato	2014
Status	Udgivet - 2014

Citationsformater

@conference{1d61d3edd2d4461b81996cb94d3b4b02,

title = "Once-daily tiotropium Respimat{\textregistered} add-on to at least medium- to high-dose ICS, with or without LABA, improves lung function in patients with symptomatic asthma, independent of allergic status",

author = "Ronald Dahl and Bateman, {Eric D} and Casale, {Thomas B} and E Pizzichini and Mark Vandewalker and JC Virchow and M Engel",

year = "2014",

language = "English",

}

TY - CONF

T1 - Once-daily tiotropium Respimat® add-on to at least medium- to high-dose ICS, with or without LABA, improves lung function in patients with symptomatic asthma, independent of allergic status

AU - Dahl, Ronald

AU - Bateman, Eric D

AU - Casale, Thomas B

AU - Pizzichini, E

AU - Vandewalker, Mark

AU - Virchow, JC

AU - Engel, M

PY - 2014

Y1 - 2014

M3 - Poster

ER -